215 results
Page 4 of 11
6-K
EX-99.1
nck7wrek
13 Aug 20
BELLUS Health Reports Second Quarter 2020 Financial Results and Business Highlights
7:00am
6-K
EX-99.1
o5o96tku4t kk
6 Jul 20
BELLUS Health Announces Topline Results from its Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
EX-99.2
eo71asy
14 May 20
Condensed Consolidated Interim Financial Statements of
5:12pm
6-K
EX-99.1
gkgoqk2ur751
14 May 20
BELLUS Health Reports First Quarter 2020 Financial Results and Business Highlights, and Provides Updates on BLU-5937
5:00pm
6-K
EX-99.1
jnwtoq6ypnmf8 33j1
8 Apr 20
Notice of Annual and Special Meeting of Shareholders
9:41am
6-K
EX-99.2
a7ab3d432t
8 Apr 20
Notice of Annual and Special Meeting of Shareholders
9:41am
6-K
EX-99.1
eor3vj627
7 Apr 20
Bellus HEALTH 2019 ANNUAL REPORT
9:59am
6-K
EX-99.1
59281y8k tsglwdxwi7
6 Apr 20
BELLUS Health Announces Completion of Dosing in Phase 2 RELIEF Trial with BLU-5937 for the Treatment of Refractory Chronic Cough
5:02pm
6-K
EX-99.1
5j2a 58q82y
23 Mar 20
Current report (foreign)
8:11am
SUPPL
9l7izfvn1tii7q8zc7p5
23 Mar 20
Supplemental materials (foreign)
7:06am
6-K
EX-99.1
ux41r
19 Mar 20
BELLUS Health Announces Completion of Enrollment in Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
40-F
nrzk4y ni100u
27 Feb 20
Annual report (Canada)
5:13pm
40-F
EX-99.1
ani6o2fnpixxsx0hj 01
27 Feb 20
Annual report (Canada)
5:13pm
40-F
EX-99.2
jxf wcm987s6cc2
27 Feb 20
Annual report (Canada)
5:13pm
40-F
EX-99.3
u92wihpvwb3dhd alk
27 Feb 20
Annual report (Canada)
5:13pm
F-10/A
6oxmdyi63i uentf0y
17 Jan 20
Registration of securities (Canada) (amended)
4:21pm
F-10
EX-4.2
w21n9dhh6
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10
EX-4.3
uaytj5
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10
EX-4.1
v6udphj e6kh
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10
7a1kof
20 Dec 19
Registration of securities (Canada)
4:03pm